TrialJournal of clinical hypertension (Greenwich, Conn.)2020

A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension.

Woohyeun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.